RNA Competitors & Alternatives
Compare Atrium Therapeutics, Inc. Common Stock with similar stocks in the same industry
Biotechnology
RNA
Main Stock$12.87
Tradestie Score
57
Market Cap
$6.27B
Revenue Growth
11.5%
Analyst Upside
+94.3%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$30.63
|
$293.03M | - | 58 | Compare |
|
OMER
Omeros Corporation
|
$10.38
|
$281.75M | 9.0 | 57 | Compare |
|
DBVT
DBV Technologies S.A.
|
$16.17
|
$275.54M | - | 54 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$2.07
|
$275.13M | - | 60 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$15.11
|
$269.08M | - | 56 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$9.16
|
$211.22M | - | 56 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$4.87
|
$202.58M | - | 59 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$17.98
|
$170.45M | - | 59 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$4.95
|
$158.43M | - | 53 | Compare |
More RNA Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2834)
222 stocks in this industry